Oncology Based Molecular Diagnostics Market

Future Market Insights

Key Insight

The oncology based molecular diagnostics market is projected to grow from USD 4.1 billion in 2025 to USD 7.0 billion by 2035, at a CAGR of 5.5%. Breast Cancer will dominate with a 18.7% market share, while reagents will lead the product outlook segment with a 58.6% share.

September 22, 2025

Anurag Sharma

250 Pages

Cite this Report

Oncology Based Molecular Diagnostics Market

https://www.futuremarketinsights.com/reports/oncology-based-molecular-diagnostics-market

License

Buy Now

Summary ToC Companies

Key Players

Abbott Laboratories
Agilent Technologies
BD (Becton
Bayer
Cepheid (Danaher Corporation)
T. Rowe Price
Dickinson
F. Hoffmann-La Roche Ltd. (Roche)
Hologic
QIAGEN N.V
Siemens
Sysmex Corporation

Methodology

Member of

Greater New York Chamber of Commerce

Recognized by

Awarded by

SILVER STEVIE® WINNER

Asia Pacific Stevie Awards - 2023

BRONZE STEVIE® Award

20th annual IBAs

Quick Contact

Chat on Whatsapp + 44 20 3769 9709 + 1 347 918 3531 Contact By Email

Get Free Sample PDF

Oncology Based Molecular Diagnostics Market

Key Players

Similar Industry Reports